U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

TNF ligands

Patent 6232446 Issued on May 15, 2001. Estimated Expiration Date: Icon_subject May 15, 2018. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

Human tumor necrosis factor
Patent #: 4677063
Issued on: 06/30/1987
Inventor: Mark ,   et al.

Antitumor active substance, process for preparing the same, drug containing the substance, gene coding for the substance, vector containing the gene and recombinant microorganism
Patent #: 4898818
Issued on: 02/06/1990
Inventor: Nakai, et al.

Novel polypeptide having an anti-tumor activity and a method of preparation thereof
Patent #: 4948875
Issued on: 08/14/1990
Inventor: Tanaka, et al.

Novel human TNF polypeptide mutants and DNA's encoding said mutants
Patent #: 4990455
Issued on: 02/05/1991
Inventor: Yamagishi, et al.

Proteins and the preparation thereof Patent #: 5344915
Issued on: 09/06/1994
Inventor: LeMaire, et al.

Inventors

Assignee

Application

No. 477347 filed on 06/07/1995

US Classes:

530/388.22, Binds receptor (e.g., transferrin receptor, Fc receptor, dihydropyridine receptor, IL-2 receptor, etc.)435/326, Animal cell, per se, expressing immunoglobulin, antibody, or fragment thereof435/331, Immunoglobulin or antibody binds a specifically identified amino acid sequence435/332, Immunoglobulin or antibody binds a microorganism or normal or mutant component or product thereof (e.g., animal cell, cell surface antigen, secretory product, etc.)435/334, Binds a receptor (e.g., transferrin receptor, Fc receptor, dihydropyridine receptor, IL-2 receptor, etc.)435/346, Fused or hybrid cell, per se530/387.1, Immunoglobulin, antibody, or fragment thereof, other than immunoglobulin antibody, or fragment thereof that is conjugated or absorbed530/387.9, Binds specifically-identified amino acid sequence530/388.1, Monoclonal530/388.2, Binds microorganism or normal or mutant component or product thereof (e.g., animal cell, cell-surface antigen, secretory product, etc.)530/389.1Polyclonal antibody or immunogloblin of identified binding specificity

Examiners

Primary: Gambel, Phillip

Attorney, Agent or Firm

Foreign Patent References

  • 5897690 AU. 04/24/1991
  • 0334185 EP. 09/24/1989
  • 0398327 EP. 11/24/1990
  • 0418014 EP. 03/24/1991
  • 0648783 EP. 04/24/1995

International Classes

C07K 016/28
C12N 005/12

Foreign Application Priority Data

1989-05-18 IL

Abstract

Antibodies to tumor necrosis factor receptors (TNF-Rs) are disclosed together with methods of producing them. The antibodies are preferably those which inhibit the cytotoxic effect of TNF but not its binding to the TNF-Rs. Most preferably, the antibodies bind to an extracellular domain of the C-terminal cysteine loop of the p75 TNF receptor, which loop consists of the amino acid sequence Cys-185 to Thr-201 of SEQ ID NO:3.

Other References

  • Chen PC et al 1995 J. Biol Chem 270(6): 2874-2888 abstract.
  • Staufer G et al 1988 J Biol Chem 263(35): 19088-19104.
  • Higuchi et al 1992 J. Biol. Chem. 267(29): 20892-20899.
  • 1. Loetscher et al. J Biol. Chem. 265: 20131-20138 (1990).
  • 2. Brockhaus et al. PNAS 87: 3127-3131 (1990).
  • 3. Weir (Ed) Handbook of Experimental Immunology vol. 1 Blackwell Scientific Publications Oxford, pp. 8.14-8.15 only.
  • Balavoine et al., "Prostaglandin E2 and Collegenase Production by . . . ," J. Clin. Invest., 78:1120-1124, 1986
  • Bentler et al., "Passive Immunization Against Cachetic/Tumor . . . ," Science, 229:869-871, 1985
  • Bentler et al., Tumor Necrosis Factors . . . , Raven Press, New York, New York, 1992, pp. 145 and 383, 1992
  • Beutler, B. et al., "Cachectin: More Than a Tumor Necrosis Factor," New Eng. J. Med., 316(7), 379-385, 1987
  • Bigda et al., "Dual Role of the p75 Tumor Necrosis Factor . . . ," J. Exp. Med., 180:445-460, 1990
  • Brockhaus, M. et al., "Monoclonal Antibodies Against the TNF-Receptor Inhibit . . . ," 2nd Int.'l Conf. Tumor Necrosis Factor and Related Cytokines, Jan. 15-20, 1989, WA 140
  • Creasey et al., "Biological Effects of Recombinant Human Tumor Necrosis . . . , " Cancer Res., 47:145-149, 1987
  • Engelmann, H. et al., "Two Tumor Necrosis Factor-Binding Proteins Purified from Human Urine," J. Biol. Chem., vol. 265, No. 3, pp. 1531-1536, Jan. 25, 1990
  • Harris et al., "Therapeutic Antibodies . . . " TIBITECH, 11: 42-45, 1993
  • Hohmann, H-P. et al., "Two Different Cell Types Have Different Major Receptors for . . . ," J. Biol Chem., vol. 264, No. 25, Sep. 5, 1989, pp. 14927-14934
  • Hohmann, H-P. et al., "Two Different Cell Types Have Different Major Receptors for . . . ," 2nd Int'l. Conf. on Tumor Necrosis Factor and Related Cytokines, Jan. 15-20, 1989, WA 143
  • Natanson et al., "Selected Treatment Strategies for Septic . . . ," Annals of Int. Med., vol. 120, pp. 771-783, (1994)
  • Parillo et al., "Pathogenic Mech. of Septic Shock," New England Journ. of Med., Mech. of Disease, vol. 328(20), 1471-1477
  • Peetre et al., "A Tumor Necrosis Factor . . . ," Eur. J. Haematol., vol. 41, pp. 414-419, 1988
  • Schall et al., Cell, vol. 61, pp. 361-370, 1990
  • Seckinger et al., "A Human Inhibitor of Tumor Necrosis Factor . . . ," J. Exp. Med., 167: 1511-1516, 1988
  • Smith et al., Science, vol. 248, pp. 1019-1023, 1990
  • Tracey, K.J. et al., "Anti-Cachetin/TNF Monoclonal Antibodies . . . ," Nature, 330: 662-664, 1987
  • Tracey, K.J. et al., "Shock and Tissue Injury Induced by Recombinant Human Cachectin," Science, vol. 234, pp. 470-474, Oct. 1986
  • Unglaub et al., "Downregulation of Tumor Necrosis Factor . . . ," J. Exp. Med., 166: 1788-1797, 1987
  • Wallach, D., "Cytotoxins (Tumor Necrosis Factor, Lymphotoxin and Others); Molecular Functional Characteristics . . . ," Interferon 7, pp. 90-124, Jul. 1986
  • Whitlow et al., "Single-Chain Fv Proteins . . . ," Methods, 2:97-105, 199
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
 
Sign InRegister
Username  
Password   
forgot password?